Search

Blood component use in the United States

“Blood transfusion is one of the most common medical procedures and can be lifesaving. In the US, approximately 11 million units of red blood cells (RBCs), 2.5 million units of platelets, 2.2 million units of plasma, and 1.2 million units of cryoprecipitate are transfused annually” Cohn and Shaz (2023).

Read More »

Neonatal PICC complication – Full Text

“Cardiorespiratory compromise due to hyperalimentation fluid extravasation caused by a peripherally inserted central venous catheter (PICC) that migrated into the mediastinum was reported previously” Alawi and Maddali (2023).

Read More »

Pediatric blood culture bottle choice

“The purpose of this study is to evaluate the usefulness of anaerobic blood culture in pediatric patients by comparing the detection rate and distribution of bacteria between aerobic and anaerobic blood culture bottles” Noh et al (2023).

Read More »

How to reduce the carbon footprint of anaesthesia – Full Text

“We identified opportunities and challenges to reducing the carbon footprint of anaesthesia in Australian hospitals by way of system-level and individual behavioural change. Our findings will be used to inform the development of communication and behavioural interventions aiming to mitigate carbon emissions of healthcare” etBreth-Petersen al (2023).

Read More »

Hepatic arterial infusion pump imaging

“Hepatic arterial infusion (HAI) pumps are used to deliver liver-directed therapy by allowing the administration of selective chemotherapy to the liver via a catheter implanted most commonly into the gastroduodenal artery connected to a subcutaneous pump” Bonde et al (2023).

Read More »

Central venous access registry development – Full Text

“Central venous access device-related complications can be life-threatening and add tens of billions of dollars to health care costs, while their incidence is most likely grossly mis- or underreported by medical institutions. In this communication, we review the challenges that impair retention, exchange, and analysis of data necessary for a meaningful understanding of critical events and outcomes in this clinical domain” Iorga et al (2023).

Read More »

IV lock salvage strategy for implantable port infections

“Little is known about efficacy and safety of ethanol lock therapy (ELT) to treat totally implantable venous access device (TIVAD) infections. The objective of this trial was to evaluate the effectiveness and safety profile of a local treatment with ELT without removal for TIVAD infection due to coagulase-negative staphylococci” Lesens et al (2023).

Read More »

Dalbavancin for skin and soft tissue infections

“With the arrival of new drugs, there is a need to refine the appropriate drug’s decision-making. Drugs with a long half-life (long-acting lipoglycopeptides such as dalbavancin or oritavancin), which allows weekly administration (or even greater), can reduce hospital admission and length of stay with fewer healthcare resources through outpatient management (home hospitalization or day hospitals)” Blanes Hernández et al (2023).

Read More »

5-FU contamination and closed-system transfer device

“Occupational exposure to cytotoxic drugs can lead to significant health problems. This study was designed to evaluate the risk of 5-fluorouracil (5-FU) contamination for nurses when disconnecting the infusion line of an elastomeric pump from a non-coring needle” Raphaëlle et al (2023).

Read More »

Vascular Access and IV Therapy Resource

"IVTEAM is a global vascular access and infusion therapy resource that provides daily updates for clinical teams. Our updates ensure health care professionals can easily keep up to date with the most relevant evidence related to vascular access and infusion therapy."
IVTEAM
IVTEAM

Resuscitation room management of patients – Full Text

“Out-of-hospital and in-hospital measures included: intravenous access (61% vs. 99%), 12-lead ECG (55% vs. 87%), invasive airway management (21% vs. 34%) invasive ventilation (21% vs. 34%), catecholamines (9% vs. 30%), arterial access (0% vs. 52%), and cardiopulmonary resuscitation (11% vs. 6%)” Dziegielewski et al (2023).

Read More »

Medical device cybersecurity in healthcare – Full Text

“All of these devices, once connected to a hospital network, present another opportunity for a malevolent party to access the hospital systems, either to gain PHI for financial, political or other gain or to attack the systems directly to cause erroneous monitoring, altered settings of any device and even to access the EMR via this IoMT window” Cartwright (2023).

Read More »

MARSI prediction in cancer patients with central venous access

“The purpose of this study was to determine the prevalence of medical adhesive-related skin injury (MARSI) at the site of central venous access device (CVAD) implantation in patients with cancer, identify risk factors associated with MARSI in patients with cancer, and create a nomogram for predicting risk of MARSI” Li et al (2023).

Read More »

Topical gentamicin for CLABSI prevention

“To compare the infection rates achieved with the application of either topical gentamicin or placebo to the exit-site of tunneled catheters filled with locking solution in chronic hemodialysis patients” Caetano et al (2023).

Read More »

Infusion-related phlebitis reduction

“Here we review the major etiologies of IRP and describe potential pharmacological and nonpharmacological interventions for preventing and managing the condition as well as for improving vascular access health in multiple-drug administration settings” Johnson et al (2023).

Read More »

Register for free citation alerts

Supporting your vascular access and infusion therapy learning journey